Peer Review History: Cardiotoxicity among Patients Using Pertuzumab, Trastuzumab and Taxane with HER2-Positive Early-Stage Breast Cancer: A Single-Centre Experience

Editor(s):

(1) Dr. Syed A. A. Rizvi, Nova Southeastern University, USA.

Reviewers:

(1) Emad Mofid Nassif Rezkallah, South Tees Hospitals NHS Foundation Trust, UK.

(2) Biswaranjan Ray, Gayatri College Of Pharmacy, India.

(3) Stoicescu Laurentiu, Iuliu Hațieganu University of Medicine and Pharmacy, Romania.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Emad Mofid Nassif Rezkallah, UK) | File 1 | NA


Stage 2 | Peer review report_2 (Biswaranjan Ray, India) | File 1 | NA


Stage 2 | Peer review report_3 (Stoicescu Laurentiu, Romania) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


 

Posted in Review History.